Novartis AG Other Adjustments To Reconcile Profit Loss
Novartis AG (NVSEF) reported Other Adjustments To Reconcile Profit Loss of $0 for the 12-month period ending 2021-12-31, per its 20-F/A filed 2023-05-15.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:OtherAdjustmentsToReconcileProfitLoss · last filed 2023-05-15
| Period end | Other Adjustments To Reconcile Profit Loss 12 month |
|---|---|
| 2021-12-31 | $0.00 20-F/A · filed 2023-05-15 |
| 2020-12-31 | -$1.00M 20-F/A · filed 2023-05-15 |
| 2019-12-31 | $1.00M 20-F · filed 2022-02-02 |
| 2018-12-31 | -$2.00M 20-F · filed 2021-01-26 |
| 2017-12-31 | $1.00M 20-F · filed 2020-01-29 |
| 2016-12-31 | $9.00M 20-F · filed 2019-01-30 |